Cargando…

Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes

BACKGROUND: An effective vaccine and new therapeutic methods for hepatitis C virus (HCV) are needed, and a potent HCV vaccine must induce robust and sustained cellular-mediated immunity (CMI). Research has indicated that adenoviral and vaccinia vectors may have the ability to elicit strong B and T c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Jie, Wen, Bo, Deng, Yao, Zhang, Ke, Chen, Hong, Wu, Xiaobing, Ruan, Li, Tan, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225406/ https://www.ncbi.nlm.nih.gov/pubmed/22054309 http://dx.doi.org/10.1186/1743-422X-8-506

Ejemplares similares

Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
por: Agrawal, Babita, et al.
Publicado: (2019)

Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles
por: Deng, Yao, et al.
Publicado: (2013)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines
por: Singh, Shakti, et al.
Publicado: (2016)

Sexual Transmission of HCV in Heterologous Monogamous Spouses
por: Rafik, Mona M., et al.
Publicado: (2014)

A recombinant DNA and vaccinia virus prime–boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice
por: Deng, Yao, et al.
Publicado: (2009)

An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication
por: Parker, Matthew A., et al.
Publicado: (2010)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Immunopotentiating and Delivery Systems for HCV Vaccines
por: Andrianov, Alexander K., et al.
Publicado: (2021)

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
por: Ling, Yue-Ming, et al.
Publicado: (2017)

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
por: Agrawal, Babita, et al.
Publicado: (2017)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

DAA Treatment Failure in a HIV/HBV/HCV Co-Infected Patient Carrying a Chimeric HCV Genotype 4/1b
por: De Francesco, Maria Antonia, et al.
Publicado: (2022)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
por: von Delft, Annette, et al.
Publicado: (2018)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
por: Hu, Longbo, et al.
Publicado: (2014)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Correlates of HCV seropositivity among familial contacts of HCV positive patients
por: La Torre, Giuseppe, et al.
Publicado: (2006)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Towards HCV extinction with modern HCV treatment? “Yes we can!”
por: Torti, C, et al.
Publicado: (2012)

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
por: Wang, Yizhong, et al.
Publicado: (2015)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Identification of novel neutralizing determinants for protection against HCV
por: Alzua, Garazi P., et al.
Publicado: (2023)

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
por: Kushner, Lauren E., et al.
Publicado: (2013)

Cellular Activation and Intracellular HCV Load in Peripheral Blood Monocytes Isolated from HCV Monoinfected and HIV-HCV Coinfected Patients
por: Dichamp, Isabelle, et al.
Publicado: (2014)

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
por: Jamalidoust, Marzieh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1u8rf20cvru56h6nqfu3m81r42